For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...

A federal judge in Washington has signaled he may accelerate the release of documents tied to Dr. Martin Luther King Jr.'s ...

A federal judge is weighing a request from the Trump administration to unseal records of the FBI's surveillance of Martin ...

While the approval is a historic event for the BiTE drug class in solid tumours, the market share opportunity is restricted ...

Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

A judge is weighing whether to release files related to the assasination of Dr. Martin Luther King Jr. earlier than planned.

A federal judge said it could take years to negotiate the release of any files related to the FBI's surveillance of the Rev. Martin Luther King Jr.

A new study is the first phase 3 to show meaningful improvement in both progression-free and overall survival with first-line ...

After one inmate died and four others were injured in a recent Bibb County Jail altercation, community leaders are urging ...

Jazz Pharma's Zepzelca plus Tecentriq significantly improved survival in a Phase 3 study for extensive-stage small-cell lung ...

Analysts said the data suggest “a strong treatment effect.” Jazz has filed for FDA approval for the combination, which could ...